{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:29:25Z","timestamp":1789435765916,"version":"build-2803163510"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Genentech, a member of the Roche Group"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/toxsci\/kfz053","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:34:16Z","timestamp":1550698456000},"page":"409-421","source":"Crossref","is-referenced-by-count":6,"title":["In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection"],"prefix":"10.1093","volume":"169","author":[{"given":"Gautham K","family":"Rao","sequence":"first","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney A","family":"Prell","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T","family":"Laing","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-6665","authenticated-orcid":false,"given":"Stefanie C M","family":"Burleson","sequence":"additional","affiliation":[{"name":"Burleson Research Technologies Inc., Morrisville, North Carolina 27560"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Nguyen","sequence":"additional","affiliation":[{"name":"OMNI Biomarker Development"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M","family":"McBride","sequence":"additional","affiliation":[{"name":"OMNI Biomarker Development"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Zhang","sequence":"additional","affiliation":[{"name":"Preclinical and Translational Pharmacokinetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sheinson","sequence":"additional","affiliation":[{"name":"Biostatistics, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy G","family":"Halpern","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2019053009503289200_kfz053-B1","doi-asserted-by":"crossref","first-page":"e1000790.","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"2019053009503289200_kfz053-B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/irv.12319","article-title":"Epidemiological and virological characteristics of influenza B: Results of the Global Influenza B Study","volume":"9","author":"Caini","year":"2015","journal-title":"Influenza Other Respir. Viruses"},{"key":"2019053009503289200_kfz053-B3","author":"CDC","year":"2018"},{"key":"2019053009503289200_kfz053-B4","doi-asserted-by":"crossref","first-page":"14234.","DOI":"10.1038\/ncomms14234","article-title":"A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action","volume":"8","author":"Chai","year":"2017","journal-title":"Nat. Commun"},{"key":"2019053009503289200_kfz053-B5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/21645515.2015.1079676","article-title":"Immunological considerations for developing antibody therapeutics for Influenza A","volume":"12","author":"Chan-Hui","year":"2016","journal-title":"Hum. Vaccin. Immunother"},{"key":"2019053009503289200_kfz053-B6","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1099\/jgv.0.000922","article-title":"Influenza virus replication in macrophages: Balancing protection and pathogenesis","volume":"98","author":"Cline","year":"2017","journal-title":"J. Gen. Virol"},{"key":"2019053009503289200_kfz053-B7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00430-014-0334-5","article-title":"Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice","volume":"203","author":"Costa","year":"2014","journal-title":"Med. Microbiol. Immunol"},{"key":"2019053009503289200_kfz053-B8","doi-asserted-by":"crossref","first-page":"29201.","DOI":"10.1038\/srep29201","article-title":"Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci. Rep"},{"key":"2019053009503289200_kfz053-B9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tra.12012","article-title":"Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans","volume":"14","author":"Flipse","year":"2013","journal-title":"Traffic"},{"key":"2019053009503289200_kfz053-B10","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","article-title":"The burden of influenza B: A structured literature review","volume":"103","author":"Glezen","year":"2013","journal-title":"Am. J. Public Health"},{"key":"2019053009503289200_kfz053-B11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cid\/ciu668","article-title":"Editorial commentary: Changing epidemiology of influenza B virus","volume":"59","author":"Glezen","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"2019053009503289200_kfz053-B12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: An historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol"},{"key":"2019053009503289200_kfz053-B13","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: Knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol. Spectr"},{"key":"2019053009503289200_kfz053-B14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/cid\/ciu664","article-title":"Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012","volume":"59","author":"Heikkinen","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"2019053009503289200_kfz053-B15","doi-asserted-by":"crossref","first-page":"200ra114.","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci. Transl. Med"},{"key":"2019053009503289200_kfz053-B16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12275-013-3428-7","article-title":"DBA\/2 mouse as an animal model for anti-influenza drug efficacy evaluation","volume":"51","author":"Kim","year":"2013","journal-title":"J. Microbiol"},{"key":"2019053009503289200_kfz053-B17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/fmb.15.120","article-title":"Knowns and unknowns of influenza B viruses","volume":"11","author":"Koutsakos","year":"2016","journal-title":"Future Microbiol"},{"key":"2019053009503289200_kfz053-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v069.i01","article-title":"Least-square means: The R Package Ismeans","volume":"69","author":"Lenth","year":"2016","journal-title":"J. Stat. Softw"},{"key":"2019053009503289200_kfz053-B19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12250-018-0009-2","article-title":"Evaluation of antibody-dependent enhancement of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine","volume":"33","author":"Luo","year":"2018","journal-title":"Virol. Sin"},{"key":"2019053009503289200_kfz053-B20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01417-16","article-title":"Influenza virus overcomes cellular blocks to productively replicate, impacting macrophage function","volume":"91","author":"Marvin","year":"2017","journal-title":"J. Virol"},{"key":"2019053009503289200_kfz053-B21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nm.2262","article-title":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes","volume":"17","author":"Monsalvo","year":"2011","journal-title":"Nat Med"},{"key":"2019053009503289200_kfz053-B22","doi-asserted-by":"crossref","first-page":"e1004031.","DOI":"10.1371\/journal.ppat.1004031","article-title":"First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies","volume":"10","author":"Ng","year":"2014","journal-title":"PLoS Pathog"},{"key":"2019053009503289200_kfz053-B23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/142.3.360","article-title":"Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control","volume":"142","author":"Nolan","year":"1980","journal-title":"J. Infect. Dis"},{"key":"2019053009503289200_kfz053-B24","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1128\/JVI.05930-11","article-title":"The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses","volume":"85","author":"Pica","year":"2011","journal-title":"J. Virol"},{"key":"2019053009503289200_kfz053-B25","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/sim.6052","article-title":"Model-based dose finding under model uncertainty using general parametric models","volume":"33","author":"Pinheiro","year":"2014","journal-title":"Stat. Med"},{"key":"2019053009503289200_kfz053-B38","author":"R Core Team","year":"2014"},{"key":"2019053009503289200_kfz053-B26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"key":"2019053009503289200_kfz053-B27","doi-asserted-by":"crossref","first-page":"e1000258.","DOI":"10.1371\/journal.pmed.1000258","article-title":"Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: Four observational studies from Canada","volume":"7","author":"Skowronski","year":"2010","journal-title":"PLoS Med"},{"key":"2019053009503289200_kfz053-B28","doi-asserted-by":"crossref","first-page":"e92153.","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS One"},{"key":"2019053009503289200_kfz053-B29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/JVI.01805-15","article-title":"Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site","volume":"90","author":"Smith","year":"2016","journal-title":"J. Virol"},{"key":"2019053009503289200_kfz053-B30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/cid\/ciu269","article-title":"Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection","volume":"59","author":"Su","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"2019053009503289200_kfz053-B31","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.00291-10","article-title":"Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice","volume":"84","author":"Tate","year":"2010","journal-title":"J. Virol"},{"key":"2019053009503289200_kfz053-B32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-dependent enhancement of virus infection and disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol"},{"key":"2019053009503289200_kfz053-B33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2217\/fmb.15.65","article-title":"Influenza B viruses: Not to be discounted","volume":"10","author":"van de Sandt","year":"2015","journal-title":"Future Microbiol"},{"key":"2019053009503289200_kfz053-B34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J. Infect. Dis"},{"key":"2019053009503289200_kfz053-B35","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol"},{"key":"2019053009503289200_kfz053-B36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat. Rev. Microbiol"},{"key":"2019053009503289200_kfz053-B37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfz053\/28453745\/kfz053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/169\/2\/409\/28745516\/kfz053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T05:31:02Z","timestamp":1662960662000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/169\/2\/409\/5362043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,22]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfz053","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,22]]}}}